Equillium (EQ) Uzoq muddatli qarzning kapitalga koeffitsiyenti

Equillium (EQ) brendining ramzi va logotipi

Equillium, Inc. (EQ) yuqori sifatli preklinik sinovlarni ta'minlovchi sertifikatlangan biotexnologiya laboratoriyalari bazasini saqlaydi. Uzoq muddatli qarzlar bo'yicha moliyaviy leveraj kapitaldagi qarz mablag'larining dinamikasini aks ettiradi, bunda 0.00 joriy metrika darajasi vazifasini bajaradi. Itolizumab dori vositasining ishlab chiqilishi autoimmun patologiyalar va transplantatsiyani rad etishni davolashga qaratilgan. Strategik sherikliklar orqali immunobiologik portfelning global miqyosda kengayishi kompaniyaga farmatsevtika bozorining salmoqli ulushlarini egallashga yordam beradi.

Uzoq muddatli qarzning kapitalga nisbati: Equillium Bio (EQ) 04.07.2022 - 30.10.2026 uchun

Equillium Inc (EQ) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Equillium Bio|EQ - Maqsadli narxlar grafigi
- bozor kapitallashuvi tafsilotlari:
Bozor qiymati Equillium, Inc.|EQ - Kompaniyaning to‘liq qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya uchun buxgalteriya qiymati Equillium|EQ - Balans kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati equilliumbio.com|EQ - Kompaniyaning yakuniy aktivlari
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Equillium, Inc.|EQ - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti Equillium Bio|EQ - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Equillium, Inc.|EQ - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari Equillium|Tezkor likvidlik koeffitsiyenti equilliumbio.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
EQ - Kompaniyaning sof foydasi
Kompaniyaning har tomonlama tahlili:EQ equilliumbio.com
equilliumbio.com yetakchi tovari

Biomateriallar xaridiga tegishli geosiyosiy murakkabliklar Equillium, Inc. (EQ) dori vositalarining bozorga chiqishini sekinlashtirmoqda. Bunday sharoitda, uzoq muddatli qarzning kapitalga nisbati kompaniyaning moliyaviy leveraj barqarorligini aks ettiradi. Ushbu ko'rsatkich muddati bir yildan ortiq bo'lgan majburiyatlarni sof aktiv qiymati bilan solishtiradi. U biznes rivojlanishining tashqi qarzlarga qanchalik bog'liqligini o'lchaydi. Ushbu grafikdagi tendentsiya balansning deleverajlanish sur'atlarini baholash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

Uzoq muddatli qarzning kapitalga nisbati argenx N.V.|Uzoq muddatli qarzning o'z kapitaliga nisbati BioNTech Group (BNTX)|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ADMA Biologics ADMA|PTGX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Immunovant - Uzoq muddatli qarzning kapitalga nisbati|KNSA - Uzoq muddatli qarzning kapitalga nisbati|GRFS (Grifols Group) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Adaptive Biotechnologies Inc. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|auriniapharma.com (AUPH) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati BioCryst Pharmaceuticals (BCRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Vera Therapeutics Inc VERA|Uzoq muddatli qarzning o'z kapitaliga nisbati Dianthus Pharma DNTH|PHVS - Uzoq muddatli qarzning o'z kapitaliga nisbati|ABCL: Uzoq muddatli qarzning o'z kapitaliga nisbati|TRML - Uzoq muddatli qarzning kapitalga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi PHAR|NKTR (Nektar) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Upstream Pharma UPB|Uzoq muddatli qarzning kapitalga nisbati ZBIO|IMNM - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Gossamer Bio GOSS|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati KalVista Pharma|SEPN: Uzoq muddatli qarzning o'z kapitaliga nisbati|PVLA - Uzoq muddatli qarzning kapitalga nisbati|SVRA: Uzoq muddatli qarzning kapitalga nisbati|RIGL - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AnaptysBio|Uzoq muddatli qarzning o'z kapitaliga nisbati ATXS|Uzoq muddatli qarzning o'z kapitaliga nisbati enGene Bio (ENGN)|Uzoq muddatli qarzning o'z kapitaliga nisbati RAPT (rapt.com)|Uzoq muddatli qarzning kapitalga nisbati JBIO (Aerovate Therapeutics)|Uzoq muddatli qarzdorlikning kapitalga nisbati aclaristx.com (ACRS)|KYTX: Uzoq muddatli qarzning o'z kapitaliga nisbati|TLSA - Uzoq muddatli qarzning kapitalga nisbati|Cabaletta Bio, Inc (CABA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Ventyx Biosciences, Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati THTX|AVTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ELDN|Uzoq muddatli qarzdorlikning kapitalga nisbati Agenus, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Climb Bio, Inc. CLYM|ZURA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|aTyr Pharma, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Adagene (ADAG) - Uzoq muddatli qarzning o'z kapitaliga nisbati|IMA (ikenaoncology.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|STTK - Uzoq muddatli qarzdorlikning kapitalga nisbati|CNTB (Connect Biopharma Holdings) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Immunic Inc IMUX|Uzoq muddatli qarzning o'z kapitaliga nisbati Atara Biotherapeutics (ATRA)|inflarx.de (IFRX) - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati X4 Pharmaceuticals, Inc. XFOR|ACET (Adicet Bio Inc.) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Celularity Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti INMB (INmune Bio Corporation)|BRNS: Uzoq muddatli qarzning kapitalga nisbati|kezarlifesciences.com (KZR) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati SAB Biotherapeutics, Inc.|AKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Enlivex Therapeutics (ENLV)|Uzoq muddatli qarzning o'z kapitaliga nisbati q32bio.com QTTB|Uzoq muddatli qarzning kapitalga nisbati GOVX (GeoVax Labs, Inc.)|Uzoq muddatli qarzning kapitalga nisbati edesabiotech.com EDSA|IBIO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CARM (Carisma Therapeutics)|XTLB: Uzoq muddatli qarzning kapitalga nisbati|BOLT - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Aptevo (APVO)|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech (AIM)|Uzoq muddatli qarzning o'z kapitaliga nisbati aditxt.com ADTX|GRI Bio Corp - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati XORTX Corp XRTX|HIND - Uzoq muddatli qarzning o'z kapitaliga nisbati|REVB (revbiosciences.com) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|INDP: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Scinai Immunotherapeutics Ltd (SCNI)|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Affimed Therapeutics AFMD|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|hookipapharma.com (HOOK) - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|IGM Biosciences - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati iTeos Therapeutics Inc ITOS|Ocean Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati TC BioPharm Ltd TCBP|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati